Utech C, Wulle K G, Bieler E U, Pfannenstiel P, Panitz N, Kiefer H
Acta Endocrinol (Copenh). 1985 Dec;110(4):493-8. doi: 10.1530/acta.0.1100493.
Ten patients with severe Graves' ophthalmopathy, resistant to other therapeutic regimens were treated with cyclosporin A (CyA) over a period of 6 months. Clinically, 9 patients improved, 2 of them only after addition of corticosteroids. Intra-ocular tension on upward gaze decreased in all of these 9 patients (P less than 0.01). In 6 patients there was a significant decrease in eye muscle thickness under the treatment (P less than 0.05) as determined by computerized tomography. Side effects (e.g., paraesthesia, proteinuria) which were observed under higher doses of CyA, disappeared after lowering the dose. In only one out of 3 patients with hypertension an antihypertensive medication became necessary. CyA appears to be a valuable drug for treatment of severe Graves' ophthalmopathy when previous therapeutic regimens turned out to be unsuccessful.
十名患有严重格雷夫斯眼病且对其他治疗方案耐药的患者接受了为期6个月的环孢素A(CyA)治疗。临床上,9名患者病情改善,其中2名仅在加用皮质类固醇后改善。这9名患者向上注视时的眼压均降低(P<0.01)。计算机断层扫描显示,6名患者在治疗期间眼肌厚度显著降低(P<0.05)。在较高剂量CyA治疗时观察到的副作用(如感觉异常、蛋白尿)在降低剂量后消失。3名高血压患者中只有1名需要使用抗高血压药物。当先前的治疗方案未成功时,CyA似乎是治疗严重格雷夫斯眼病的一种有价值的药物。